Boehringer Deal Leads EU Watchdog To Close Probe

Law360, New York (July 6, 2011, 1:51 PM EDT) -- The European Commission closed its probe Wednesday into claims that Boehringer Ingelheim GmbH abused the patent system to corner the multibillion-dollar market for emphysema and related lung disease treatments after the German drugmaker settled with rival Almirall SA.

The four-year-old investigation stemmed from Almirall's complaint that in a bid to block its would-be competitor, Boehringer misled the European regulators in order to patent new treatments for chronic obstructive pulmonary disease based in part on a new active ingredient discovered by Barcelona-based Almirall.

At the urging of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.